Home / Products / Cancer (Tumor) Cell Lines / TTA-1
TTA-1
Datasheet Protocol

TTA-1

Cat. No. ARC0963
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Thyroid gland

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

TTA-1 is a cancer cell line of thyroid gland anaplastic carcinoma, isolated from in situ; thyroid gland.

Recommended Products

CAPZA1 Knockout HEK293T Polyclonal Cells CAPZA1 Knockout HEK293T Polyclonal Cells Cat. No. ARG38030 NEK9 Knockout NCI-H1975 Polyclonal Cells NEK9 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG17005 AEBP2 Knockout NCI-H1975 Polyclonal Cells AEBP2 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG31043 C2CD5 Knockout HAP1 Polyclonal Cells C2CD5 Knockout HAP1 Polyclonal Cells Cat. No. ARG27448 BRPF3 Knockout huh-7 Polyclonal Cells BRPF3 Knockout huh-7 Polyclonal Cells Cat. No. ARG28118 LRP4 Knockout HEK293T Polyclonal Cells LRP4 Knockout HEK293T Polyclonal Cells Cat. No. ARG4172
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Thyroid gland
Disease:
Anaplastic carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
64 years
Sex of Donor:
Male
Derived From Site:
In situ; Thyroid gland
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

PAK2 Knockout Jurkat Polyclonal Cells

PAK2 Knockout Jurkat Polyclonal Cells

Cat. No. ARG12914
 LACTB2 Knockout Raji Polyclonal Cells

LACTB2 Knockout Raji Polyclonal Cells

Cat. No. ARG23944
 AKR1B1 Knockout NCI-H1299 Polyclonal Cells

AKR1B1 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30289
 CAB39L Knockout NCI-H1299 Polyclonal Cells

CAB39L Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG41714
 CAMK2A Knockout AGS Polyclonal Cells

CAMK2A Knockout AGS Polyclonal Cells

Cat. No. ARG41958
 CDKN1A Knockout MES-OV Polyclonal Cells

CDKN1A Knockout MES-OV Polyclonal Cells

Cat. No. ARG6455